Prostate Health Index density improves detection of clinically significant prostate cancer.
about
Advances in Biomarkers for PCa Diagnostics and Prognostics-A Way towards Personalized Medicine.Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators.Best of the 2017 AUA Annual Meeting: Highlights From the 2017 American Urological Association Annual Meeting, May 12-16, 2017, Boston, MA.Emerging biomarkers in the diagnosis of prostate cancer.Biomarkers in active surveillance.
P2860
Prostate Health Index density improves detection of clinically significant prostate cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Prostate Health Index density ...... y significant prostate cancer.
@en
type
label
Prostate Health Index density ...... y significant prostate cancer.
@en
prefLabel
Prostate Health Index density ...... y significant prostate cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Prostate Health Index density ...... y significant prostate cancer.
@en
P2093
Darian Andreas
Herbert B Carter
Joseph Agostino
Kamyar Ghabili
Lori J Sokoll
Meera Chappidi
Mufaddal Mamawala
Patrick Mullane
Sasha C Druskin
P2860
P356
10.1111/BJU.13762
P577
2017-01-06T00:00:00Z